查詢結果分析
來源資料
相關文獻
- 白內障囊外摘除合併後房人工水晶體植入術對於虹彩切除術後眼壓控制良好之隅角閉鎖性青光眼的影響
- 無後囊支撐的後房人工水晶體植入術--初報
- Correlation between Anterior Lens Curvature and Primary Angle-Closure Glaucoma
- Biometric Study of Acute Primary Angle-Closure Glaucoma
- 結合晶體乳化術玻璃體切除術及後房人工水晶體植入術
- Characteristics of Optic Disc Changes in Taiwanese Patients with Primary Angle-Closure Glaucoma
- 急性隅角閉鎖性青光眼雷射治療與小樑切除術之比較
- 高度近視併原發性隅角閉鎖性青光眼--病例報告
- Vitreous Aspiration and Phacoemulsification in the Management of Uncontrolled Acute Primary Angle-Closure Glaucoma after YAG Laser Iridotomy
- 抗癌劑Mitomycin-C輔助小梁切除術的青光眼眼壓控制效果一年以上之追蹤成績
頁籤選單縮合
題名 | 白內障囊外摘除合併後房人工水晶體植入術對於虹彩切除術後眼壓控制良好之隅角閉鎖性青光眼的影響 |
---|---|
作者姓名(中文) | 賴盈州; 鄧美琴; 蔡盈德; | 書刊名 | 中華民國眼科醫學會雜誌 |
卷期 | 34:2 1995.06[民84.06] |
頁次 | 頁88-95 |
分類號 | 416.748 |
關鍵詞 | 白內障囊外摘除; 後房人工水晶體植入術; 虹彩切除術; 眼壓控制; 隅角閉鎖性青光眼; Angle-closure glaucoma; Intraocular pressure; Iridectomy; Extracapsular cataract extraction; |
語文 | 中文(Chinese) |
中文摘要 | 從1988年12月到1990年11月兩年內,共有23個虹彩切除術後眼壓控制良 好之隅角閉鎖性青光眼病人(30隻眼睛),接受白內障囊外摘除合併後房人工水晶 體植入的手術,平均年齡73歲(65~79歲),術後至少追蹤半年以上且於追蹤期間均 未接受雷射後囊切開術的治療。術前的平均眼壓為15.8±3.9mmHg,術後一年內 之平均眼壓介於10.3到10.7mmHg,平均眼壓下降4.9到5.5mmHg。術後一年內平均 使用青光眼藥物減少0.23到0.36種,63的眼睛於術前不須使用青光眼藥物,術後 一年有81的眼睛不須使用青光眼藥物,只有3的眼睛於術後6個月較術前使用更多 青光眼的藥物 。術前眼壓較高者(>15mmHg)其術後眼壓下降的輻度較大且使用 青光眼藥物減少的量亦較多。術前垂直C/D比較大者(>O.6),於術前及術後均須使 用較多的青光眼藥物,使眼壓控制得更理想。眼壓下降的輻度與術前眼球軸長 度,眼球前房隅角周邊黏連與否及術前使用青光眼藥物與否並無統計學上的差 異。 因此虹彩切除術後眼壓控制良好之隅角閉鎖性青光眼病人,在接受自內障囊外摘 除合併後房人工水晶體植入的手術後,其眼壓更容易控制。 |
英文摘要 | From Dec. 1988 to Nov. 1990, thirty eyes of 23consecutive patients with angle-closure glaucomaundergoing extracapsular cataract extraction (ECCE)and posterior chamber intraocular lens (PCIOL)implantation were studied retrospectively to assessthe effect of ECCE on intraocular pressure control. The mean reduction ofl.O.P 12 months afteroperation was between 4.9 mmHg and 5.5 mmHgand the mean reduction of medications 12 monthsafter operation was between 0.23 and 0.36. 19 eyes(63) needed no antiglaucomatous medicationsbefore operation and 22 eyes (81) needed noantiglau-comatous medications after operation; onlyone eye (4) needed more antiglaucomatous medications 12 months after operation. Patients withhigher pre-operative I.O.P.(>15 mmHg) had greatermean reduction of I.O.P after operation, but, neededmore antiglaucomatous medications before and afteroperation. Patients with larger vertical C/D ratio(>0.6) usually needed more antiglaucomatousmedications before and after operation. The mean reduction of I.O.P. after operation wasnot associated with pre-operative axial length,presence ofP.A.S before operation and preoperativeuse of antiglaucomatous medications. ECCE with PCIOL implantation could be helpfulto the control of I.O.P. in patients with angle-closureglaucoma after iridectomy. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。